Wright Therapy raises $3M Series B for home-use pneumatic compression devices

Devicemaker Wright Therapy Products attracted a $3 million Series B financing round in a venture deal that reflects the current industry investment focus on stability, approved products and cost-effective care. Wright, which is based in Pittsburgh, PA, makes pneumatic compression devices for home use to treat lymphedema and chronic venous insufficiency. Many already have 510(k) clearance, and the company plans to use the money to expand its marketing and product development. Most of the funding came through high-net-worth angel investors via Eagle Ventures. Item

Suggested Articles

Infectious disease blood tester Karius has raised $165 million led by SoftBank’s Vision Fund 2, the Japanese conglomerate’s sequel to its VC megafund.

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

Drug-pricing watchdog ICER has partnered with medical data firm Aetion to help analyze the real-world performance of different treatments.